Rgc stock forecast revisions this week were upward after

RGC stock forecast revisions this week were upward after management reaffirmed its guidance and reported stronger contract pipelines than initially projected. And Paul will discuss the full year's capital spending projection shortly. And now I'm going to turn it over to Tim Mulvaney, our Treasurer and CFO, who will discuss our financial results. Tim? Recent news coverage has consistently listed RGC among the day’s biggest gainers. On May 6, RGC’s 42% leap was noted alongside other high-flyers, and on May 8 and 9, the stock continued to feature prominently in roundups of top-performing equities. However, the supplied sources do not attribute RGC’s gains to any specific company announcement, earnings report, or industry development. Instead, the headlines simply highlight the magnitude of the move, confirming that Regencell Bioscience Holdings Ltd (RGC) is on the radar of momentum traders and growth-focused investors. Technical traders see RGC stock forecast upside as the 50-day moving average crosses above the 200-day, a bullish golden cross pattern signaling sustained upward momentum.